Skip to content
HowShorted

Protara Therapeutics, Inc. short interest in 2021

In 2021, Protara Therapeutics, Inc.'s disclosed short interest ran from 0.97% of shares outstanding on 15 Jan 2021 to 3.37% on 31 Dec 2021, a change of +2.40 percentage points. The year's high was 3.48% on 15 Dec 2021 and its low 0.97% on 15 Jan 2021, averaging 2.11% across 22 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 6.31 days on 13 Aug 2021. Full history: Protara Therapeutics, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Protara Therapeutics, Inc. in 2021

2021 in figures

Start of year
0.97% (15 Jan 2021)
End of year
3.37% (31 Dec 2021)
Change
+2.40 pp
High
3.48% (15 Dec 2021)
Low
0.97% (15 Jan 2021)
Average
2.11%
Highest days to cover
6.31 (13 Aug 2021)
SEC filings marked
6

Every report in 2021

Protara Therapeutics, Inc. short interest in 2021
SettlementShort interestDays to coverFilings since previous
15 Jan 20210.97%1.33
29 Jan 20211.21%1.98
12 Feb 20211.21%1.64
26 Feb 20211.38%1.87
15 Mar 20211.85%2.2310-K filed
31 Mar 20212.57%2.84
15 Apr 20212.54%3.29
30 Apr 20213.06%1.44
14 May 20212.73%1.9710-Q filed
28 May 20212.70%5.59
15 Jun 20212.77%2.31
30 Jun 20211.32%1.00
15 Jul 20211.69%2.17
30 Jul 20211.72%4.46
13 Aug 20211.68%6.3110-Q filed, results (8-K)
31 Aug 20211.84%1.31
15 Sep 20211.80%3.97
30 Sep 20211.15%1.00
15 Nov 20212.84%2.6910-Q filed, results (8-K)
30 Nov 20212.63%3.43
15 Dec 20213.48%5.71
31 Dec 20213.37%3.69

See also: Protara Therapeutics, Inc.'s full history · most shorted US stocks of 2021 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.